Summary GL Pharm Tech Corp (GL Pharm) is a pharmaceutical company.The company offers drug formulations and delivery technologies for generic marketed drug.
It provides incrementally modified drugs, generic drugs, and G-SOREN Tab.GL Pharm provides generic drugs such as olmesartan, atorvastatin, lercanidipine, losartan, ramipril, sarpogrelate, simvastatin, tamsulosin, pregabalin, and rabeprazole, among others in the areas of cardiovascular, pain management, urology, anti – infection, gastric disease, diabetes, CNS disease and others.
The company’s G-SOREN Tablet is an oral herbal product for the prevention and treatment of gastritis.It markets products though its distributors across Europe, Japan and the US.
GL Pharm is headquartered in Seongnam, South Korea.
GL Pharm Tech Corp (204840) - Pharmaceuticals & Healthcare - Deals and Alliances Profile provides you comprehensive data and trend analysis of the company’s Mergers and Acquisitions (M&As), partnerships and financings.The report provides detailed information on Mergers and Acquisitions, Equity/Debt Offerings, Private Equity, Venture Financing and Partnership transactions recorded by the company over a five year period.
The report offers detailed comparative data on the number of deals and their value categorized into deal types, sub-sector and regions.
GlobalData derived the data presented in this report from proprietary in-house Pharma eTrack deals database, and primary and secondary research.
Scope - Financial Deals - Analysis of the company’s financial deals including Mergers and Acquisitions, Equity/Debt Offerings, Private Equity, Venture Financing and Partnerships. - Deals by Year - Chart and table displaying information encompassing the number of deals and value reported by the company by year, for a five year period. - Deals by Type - Chart and table depicting information including the number of deals and value reported by the company by type such as Mergers and Acquisitions, Equity/Debt Offering etc. - Deals by Region - Chart and table presenting information on the number of deals and value reported by the company by region, which includes North America, Europe, Asia Pacific, the Middle East and Africa and South and Central America. - Deals by Sub-sector - Chart and table showing information on the number of deals and value reported by the company, by sub-sector. - Major Deals - Information on the company’s major financial deals. Each such deal has a brief summary, deal type, deal rationale; and deal financials and target Company’s (major public companies) key financial metrics and ratios. - Business Description - A brief description of the company’s operations. - Key Employees - A list of the key executives of the company. - Important Locations and Subsidiaries - A list and contact details of key centers of operation and subsidiaries of the company. - Key Competitors - A list of the key competitors of the company. - Key Recent Developments - A brief on recent news about the company.
Reasons to Buy Get detailed information on the company’s financial deals that enable you to understand the company’s expansion/divestiture and fund requirements - The profile enables you to analyze the company’s financial deals by region, by year, by business segments and by type, for a five year period.
Understand the company’s business segments’ expansion / divestiture strategy - The profile presents deals from the company’s core business segments’ perspective to help you understand its corporate strategy.
Access elaborate information on the company’s recent financial deals that enable you to understand the key deals which have shaped the company - Detailed information on major recent deals includes a summary of each deal, deal type, deal rationale, deal financials and Target Company’s key financial metrics and ratios.
Equip yourself with detailed information about the company’s operations to identify potential customers and suppliers. - The profile analyzes the company’s business structure, locations and subsidiaries, key executives and key competitors.
Stay up-to-date on the major developments affecting the company - Recent developments concerning the company presented in the profile help you track important events.
Gain key insights into the company for academic or business research - Key elements such as break up of deals into categories and information on detailed major deals are incorporated into the profile to assist your academic or business research needs.
Note*: Some sections may be missing if data is unavailable for the company.
Our reports have been used by over 10K customers, including:
200 pages •
By The Business Research Company
• Mar 2021
Major players in the artificial intelligence (AI) in pharma market are Novartis, IBM Watson, Microsoft Corporation, Merck, GNS Healthcare., Google, AstraZeneca, Atomwise, Inc., Exscientia, and Cyclica. The global AI in pharma market is expected to grow from $0.91 billion in 2020 to $1.27 billion in 2021 at a compound annual growth rate...
187 pages •
By Global Industry Analysts
• Apr 2021
Abstract:
- Global Testosterone Replacement Therapy (TRT) Market to Reach $2.2 Billion by 2027
- Amid the COVID-19 crisis, the global market for Testosterone Replacement Therapy (TRT) estimated at US$1.7 Billion in the year 2020, is projected to reach a revised size of US$2.2 Billion by 2027, growing at a CAGR of...
185 pages •
By Global Industry Analysts
• Apr 2021
Abstract:
- Global Chloroacetyl Chloride Market to Reach $600.6 Million by 2027
- Amid the COVID-19 crisis, the global market for Chloroacetyl Chloride estimated at US$456.8 Million in the year 2020, is projected to reach a revised size of US$600.6 Million by 2027, growing at a CAGR of 4% over the analysis period 2020-2027....
194 pages •
By Global Industry Analysts
• Apr 2021
Abstract:
- Global Inulin Market to Reach $3.3 Billion by 2027
- Amid the COVID-19 crisis, the global market for Inulin estimated at US$1.9 Billion in the year 2020, is projected to reach a revised size of US$3.3 Billion by 2027, growing at a CAGR of 8.2% over the analysis period 2020-2027. Food & Beverage, one of...
289 pages •
By Global Industry Analysts
• Apr 2021
Abstract:
- Global Superdisintegrants Market to Reach $649.7 Million by 2027
- Amid the COVID-19 crisis, the global market for Superdisintegrants estimated at US$413.7 Million in the year 2020, is projected to reach a revised size of US$649.7 Million by 2027, growing at a CAGR of 6.7% over the analysis period 2020-2027....
284 pages •
By Global Industry Analysts
• Apr 2021
Abstract:
- Global Pharmaceutical Hot Melt Extrusion Equipment Market to Reach $38.9 Million by 2027
- Amid the COVID-19 crisis, the global market for Pharmaceutical Hot Melt Extrusion Equipment estimated at US$29.9 Million in the year 2020, is projected to reach a revised size of US$38.9 Million by 2027, growing at...
189 pages •
By Global Industry Analysts
• Apr 2021
Abstract:
- Global Campesterol Market to Reach $217.4 Million by 2027
- Amid the COVID-19 crisis, the global market for Campesterol estimated at US$126.8 Million in the year 2020, is projected to reach a revised size of US$217.4 Million by 2027, growing at a CAGR of 8% over the analysis period 2020-2027. Food Ingredients,...
184 pages •
By Global Industry Analysts
• Apr 2021
Abstract:
- Global Glutamic Acid Market to Reach $11.1 Billion by 2027
- Amid the COVID-19 crisis, the global market for Glutamic Acid estimated at US$8 Billion in the year 2020, is projected to reach a revised size of US$11.1 Billion by 2027, growing at a CAGR of 4.8% over the analysis period 2020-2027. Food, one...
196 pages •
By Global Industry Analysts
• Apr 2021
Abstract:
- Global Halal Ingredients Market to Reach $68.2 Billion by 2027
- Amid the COVID-19 crisis, the global market for Halal Ingredients estimated at US$48.3 Billion in the year 2020, is projected to reach a revised size of US$68.2 Billion by 2027, growing at a CAGR of 5.1% over the analysis period 2020-2027....
271 pages •
By Global Industry Analysts
• Apr 2021
Abstract:
- Global Myasthenia Gravis Treatment Market to Reach $2 Billion by 2027
- Amid the COVID-19 crisis, the global market for Myasthenia Gravis Treatment estimated at US$1.3 Billion in the year 2020, is projected to reach a revised size of US$2 Billion by 2027, growing at a CAGR of 6.3% over the analysis period...
Pharmaceutical
World
China
United States
By continuing to use this site you consent to the use of cookies on your device as described in our Cookie Policy unless you have disabled them.
You can change your Cookie Settings at any time but parts of our site will not function correctly without them.